<DOC>
	<DOC>NCT00161980</DOC>
	<brief_summary>This study will monitor the safety of FS VH S/D and will evaluate whether FS VH S/D is superior to conventional surgical procedures in the reduction of lymphatic leakage by sealing the axillary lymphatics in subjects undergoing lumpectomy and level I and II axillary lymph node dissection with two separate incisions.</brief_summary>
	<brief_title>Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites</brief_title>
	<detailed_description />
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Written informed consent has been obtained from the subject prior to FS VH S/D administration Female subjects &gt;= 19 years of age Subjects with breast cancer scheduled to undergo lumpectomy of the breast and level I and II axillary lymphadenectomy with two separate incisions Subjects with known hypersensitivity to aprotinin or other components of the product Subjects with immunodeficiency Subjects with increased red cell production (e.g., in hemolytic anemia) Subjects with coagulation disorders shown by exceeding the normal range of any of following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT), fibrinogen level, or thrombocytes. Subjects having previously had axillary surgery Subjects having undergone irradiation therapy to the axillary tissue Subjects having ever received chemotherapy before the surgery</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Axillary wound</keyword>
	<keyword>Seroma</keyword>
	<keyword>Fistulae</keyword>
</DOC>